Imovax Rabies Kit
NDC Package 49281-252-51

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Imovax Rabies (rabies virus strain pm-1503-3m antigen (propiolactone inactivated) and water) kits is imovax Rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies. This formulation utilizes a kit delivery system. Marketed by Sanofi Vaccines Us Inc., this product is identified by NDC 49281-252 and is authorized under FDA application BLA103931.

Identification & Billing

NDC Package Code
49281-252-51
Package Description
1 KIT in 1 PACKAGE * 1 mL in 1 VIAL, SINGLE-USE (49281-246-58) * 1 mL in 1 SYRINGE (49281-263-58)
Product Code
49281-252
11-Digit Billing Format
49281025251
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
RxNorm Crosswalk
  • RxCUI: 830467 - rabies virus vaccine (generic for Imovax) 2.5 UNT in 1 ML Injection
  • RxCUI: 830467 - 1 ML rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML Injection
  • RxCUI: 830467 - rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT per 1 ML Injection
  • RxCUI: 830470 - IMOVAX rabies vaccine 2.5 UNT in 1 ML Injection
  • RxCUI: 830470 - 1 ML rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML Injection [Imovax]

Clinical Specifications

Proprietary Name
Imovax Rabies
Non-Proprietary Name
Rabies Virus Strain Pm-1503-3m Antigen (propiolactone Inactivated) And Water
Dosage Form
Kit - A packaged collection of related material.
Usage Information
Imovax Rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies. Imovax Rabies vaccine is approved for use in all age groups.

Regulatory & Marketing

Labeler Name
Sanofi Vaccines Us Inc.
Product Type
Vaccine
FDA Application #
BLA103931
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
10-25-2019
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49281-252-51 identifies a specific commercial package of 1 kit in 1 package * 1 ml in 1 vial, single-use (49281-246-58) * 1 ml in 1 syringe (49281-263-58) of Imovax Rabies, a vaccine label labeled by Sanofi Vaccines Us Inc.. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sanofi Vaccines Us Inc. on October 25, 2019. The current certification is valid through December 31, 2027.

How is this Sanofi Vaccines Us Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49281025251. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49281-252-51
11-Digit CMS (5-4-2)
49281-0252-51

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.